APYX insider buying
Apyx Medical Corp
Every qualifying open-market purchase of APYX reported to the SEC on Form 4, parsed directly from the filings and linked back to the source on EDGAR. No buying cluster — two or more distinct insiders inside a rolling window — has been detected in APYX yet; if one forms, it appears here (and hits our alert subscribers in real time).
All notable open-market buys in APYX
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Aug 13, 2024 | Chief Financial Officer | 5,336 | $1.13 | $6.0K | SEC ↗ |
APYX insider buying — FAQ
- Are insiders buying APYX stock?
- 1 insider has bought APYX (Apyx Medical Corp) on the open market, most recently on Aug 13, 2024. No cluster buy — two or more distinct insiders within a rolling window — has been detected yet.
- How much APYX stock have insiders bought?
- Insiders have bought a combined $6.0K of APYX across 1 open-market purchase, based on SEC Form 4 filings.
- What is an insider cluster buy in APYX?
- A cluster buy is two or more distinct Apyx Medical Corp insiders — officers, directors, or 10% owners — each buying APYX on the open market within a rolling window. None has been detected in APYX yet.
- Where does this APYX insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in APYX
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy APYX within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding APYX.